side effects of glp 1 oral Long-Term GLP-1 Medications: What You Should Know Oral GLP-1 Analogues (Semaglutide) -

Current Food and Drug Administration (FDA)Approved and Investigational GLP-1RAs Exenatide, the first FDA-approved GLP-1RA (2005), showed potential for significant weight loss, though more evidence is needed for use in treating uncomplicated obesity [1619]

Do GLP-1 medications replace insulin

This concept could explain the discrepancies in the literature regarding the satiating effects of peripheral GLP-1

In diabetes-related AD, GLP-1 promotes mitochondrial biogenesis and the antioxidant system by regulating the PGC-1a signaling pathway in vivo to directly reverse tau hyperphosphorylation.46 GLP-1(9-36) (amide) reduced elevated levels of mitochondrial-derived ROS in the hippocampus of AD model (APP/PS1) mice.47 Exendin-4 significantly increased amyloid protein (A)-induced reduction in mitochondrial function, integrity, respiratory control rate, and mitochondrial P/O ratio in all brain regions and decreased A-induced increase in the mitochondrial complex enzyme-I, IV, and V activities in all brain regions.36 Exenatide also improved hippocampal mitochondrial morphology and dynamics and reduced oxidative stress in the hippocampus of AD model (5xFAD) mice.48 The mechanism by which GLP-1 RA regulates mitochondrial function and oxidative stress has not been well elucidated

Conclusion Forced degradation studies are not merely a regulatory checkbox for GLP-1 peptide drugs, they are foundational to understanding molecular stability, impurity formation, and long-term product safety